XERS

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Xeris Biopharma Holdings (XERS) Earnings Date & Reports

Industry: @Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

XERS is expected to report earnings to fall 42.36% to -6 cents per share on March 05

Xeris Biopharma Holdings XERS Stock Earnings Reports

Q4'24

Est.

$-0.06

Q3'24

Missed

by $0.02

Q2'24

Est.

$-0.10

Q1'24

Missed

by $0.04

Q4'23

Missed

by $0.01

The last earnings report on November 08 showed earnings per share of -10 cents, missing the estimate of -9 cents. With 1.30M shares outstanding, the current market capitalization sits at 508.37M.

View a ticker or compare two or three

Compare

XERS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For XERS
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for XERS (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a developer of ready-to-use, liquid-stable injectables

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

1375 West Fulton Street

Phone

+1 844 445-5704

Employees

377

Web

https://www.xerispharma.com